Press Releases

09.08.2014
Ophthotech Corporation Achieves $50 Million Milestone under Ex-US Licensing and Commercial Agreement with Novartis for Fovista®
09.02.2014
Ophthotech Corporation to Present at the 2014 Morgan Stanley Global Healthcare Conference
08.06.2014
Ophthotech Reports Second Quarter 2014 Financial Results and Provides Business Update
08.05.2014
Ophthotech Initiates First of Several Expansion Studies to Further Evaluate Fovista® (Anti-PDGF) Therapy in Patients with Wet Age-Related Macular Degeneration
07.29.2014
Ophthotech Corporation to Announce Second Quarter 2014 Financial Results and Host Conference Call on Wednesday, August 6, 2014
05.19.2014
Ophthotech Corporation Enters into Ex-US Licensing and Commercialization Agreement for Fovista® with Novartis
05.13.2014
Ophthotech Reports First Quarter 2014 Financial Results and Provides Business Update
05.08.2014
Ophthotech Corporation to Announce First Quarter 2014 Financial Results and Host Conference Call on Tuesday, May 13, 2014
03.05.2014
Ophthotech Corporation to Present at the 2014 Barclays Capital Global Healthcare Conference
03.04.2014
Ophthotech to Host R&D Day on March 7, 2014